Want to join the conversation?
Goldman Sachs analyst Joseph Ritchie questions $ROP whether there were any mix issues that impacted 1H16 GM beyond just M&A in the Medical segment. CEO Brian Jellison says that M&A does have impact on GM and the relative mix so far this year is also a contributor. $ROP believes that the remainder of the year is driven more by medical product sales.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.
$RAI has received a $47 billion take over offer from British tobacco giant British American Tobacco! This is huge!